Development of Syringaldehyde as an Agonist of the GLP-1 Receptor to Alleviate Diabetic Disorders in Animal Models
Article in Pharmaceuticals (April 2024)
The most recent citing publications are shown below. View all 103 publications that cite this research output on Dimensions.
Article in Pharmaceuticals (April 2024)
Article in Biomedicine & Pharmacotherapy (January 2024)
Article in Drugs (December 2023)